1. Home
  2. MYPS vs ENTX Comparison

MYPS vs ENTX Comparison

Compare MYPS & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PLAYSTUDIOS Inc.

MYPS

PLAYSTUDIOS Inc.

HOLD

Current Price

$0.48

Market Cap

55.5M

Sector

Technology

ML Signal

HOLD

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.25

Market Cap

62.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYPS
ENTX
Founded
2011
2010
Country
United States
Israel
Employees
543
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.5M
62.6M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
MYPS
ENTX
Price
$0.48
$1.25
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.00
$9.00
AVG Volume (30 Days)
505.1K
138.7K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
N/A
$42,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$19.14
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$0.91
52 Week High
$1.60
$3.22

Technical Indicators

Market Signals
Indicator
MYPS
ENTX
Relative Strength Index (RSI) 52.65 51.94
Support Level $0.42 $1.17
Resistance Level $0.51 $1.37
Average True Range (ATR) 0.05 0.10
MACD 0.01 0.01
Stochastic Oscillator 44.75 61.67

Price Performance

Historical Comparison
MYPS
ENTX

About MYPS PLAYSTUDIOS Inc.

PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Companies games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: